# DCOY (Decoy Therapeutics Inc.) - SEC EDGAR Financial Statements

> Decoy Therapeutics Inc. reported $8.79M in total assets and a net loss of $16.56M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/DCOY
- Markdown: https://convexityos.com/fundamentals/DCOY.md
- SEC CIK: 0001615219
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001615219&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$16.96M | Operating profit |
| Net Income | FY 2025 | -$16.56M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$19.59 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$5.40M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $8.17M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $1.84M | $5.23M | $3.47M | $1.95M | $1.27M | $1.01M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $431K | $507K | $663K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $1.52M | $768K | $348K |
| Research & Development | $368K | $770K | $7.17M | $15.84M | $8.55M | $6.91M | $4.02M | $1.29M | $16.99M | $20.38M |
| Total Operating Expenses | $12.61M | $5.73M | $12.89M | $31.84M | $14.65M | $13.02M | $11.73M | $3.64M | $36.00M | $40.90M |
| **Operating Income** | -$12.61M | -$5.73M | -$12.89M | -$31.84M | -$12.81M | -$7.79M | -$8.27M | -$1.68M | -$34.73M | -$39.89M |
| **EBITDA** | -$12.61M | -$5.73M | -$12.88M | -$31.83M | -$12.79M | -$7.77M | -$8.14M | -$1.67M | -$34.40M | -$39.61M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | $152K | $292K | $393K |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | $0 | -- | -- | -- |
| **Net Income** | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$1.67M | -$34.43M | -$39.49M |
| Basic EPS | -$5,361,295.68 | -$2,887,873.75 | -$229,876,003.56 | -$890,189,963.03 | -$461,845,867.92 | -$747,807,428.62 | -$3,170,703,497.35 | -$1,734,913,234.40 | -$2,976,273,565.90 | -$3,634,344,103.09 |
| **Diluted EPS** | -$5,361,295.68 | -$2,887,873.75 | -$229,876,003.56 | -$890,189,963.03 | -$461,845,867.92 | -$747,807,428.62 | -$3,170,703,497.35 | -$1,734,913,234.40 | -$2,976,273,565.90 | -$3,634,344,103.09 |
| Basic Shares Outstanding | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $307K | $228K | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $1.57M | $1.30M | $750K | $114K | $62K | $116K | $76K | $175K |
| Total Operating Expenses | $3.32M | $2.63M | $2.28M | $9.03M | $895K | $966K | $1.72M | $1.49M |
| **Operating Income** | -$3.01M | -$2.63M | -$2.28M | -$9.03M | -$895K | -$966K | -$1.72M | -$1.49M |
| **EBITDA** | -$2.99M | -$2.62M | -$2.28M | -$9.03M | -$894K | -$964K | -$1.72M | -$1.49M |
| **Net Income** | -$2.99M | -$2.37M | -$2.22M | -$8.98M | -$873K | -$958K | -$1.71M | -$1.46M |
| Basic EPS | -$3.53 | -$4.46 | -$746.43 | -- | -$21.76 | -$81.21 | -$42,869.64 | -- |
| **Diluted EPS** | -$3.53 | -$4.46 | -$746.43 | -- | -$21.76 | -$81.21 | -$42,869.64 | -- |
| Basic Shares Outstanding | 845.4K | 532.0K | 3.0K | -- | 40.1K | 11.8K | 40 | -- |
| Diluted Shares Outstanding | 845.4K | 532.0K | 3.0K | -- | 40.1K | 11.8K | 40 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.71M | $2.43M | $5.90M | $12.11M | $29.21M | $11.12M | $3.74M | $3.23M | $19.19M | $22.42M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 | $14.13M | $38.66M |
| **Cash & Short-Term Investments** | $10.71M | $2.43M | $5.90M | $12.11M | $29.21M | $11.12M | $3.74M | $3.23M | $33.32M | $61.07M |
| Accounts Receivable, Net | -- | -- | -- | -- | $1.60M | $3.90M | $0 | $9.9K | $10K | $12K |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $187K | $432K | $454K |
| Other Current Assets | $275K | $44K | $151K | $168K | $173K | $138K | $136K | $22K | -- | -- |
| **Total Current Assets** | $10.99M | $2.99M | $6.52M | $14.52M | $30.16M | $15.80M | $4.69M | $6.38M | $34.54M | $62.47M |
| Property, Plant & Equipment, Net | $41K | $0 | -- | -- | $7.9K | $23K | $25K | $38K | $331K | $556K |
| Goodwill | -- | -- | -- | $0 | $8.87M | $8.87M | $8.87M | $0 | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | $31K | $35K | $67K | $131K | $194K | $247K | $309K | $195K | $0 | $65K |
| **Total Non-Current Assets** | $72K | $35K | $67K | $131K | $10.67M | $9.14M | $9.20M | $233K | $458K | $748K |
| **Total Assets** | $11.06M | $3.02M | $6.59M | $14.65M | $40.83M | $24.93M | $13.89M | $6.61M | $34.99M | $63.21M |
| Accounts Payable | $941K | $937K | $603K | $2.86M | $1.54M | $1.85M | $1.79M | $380K | $2.00M | $1.19M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $0 | $542K | $4.01M | $72K | $88K |
| Other Current Liabilities | $2.3K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $5.17M | $1.51M | -- | -- | -- | -- | -- | $1.11M | $5.85M | $3.89M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $0 | $0 | -- | -- | -- | -- | -- | $6.78M | $39K | $8.4K |
| **Total Liabilities** | $5.17M | $1.51M | $1.30M | $4.27M | $2.11M | $2.77M | $3.31M | $7.88M | $5.89M | $3.90M |
| Common Stock | $53 | $1 | $49 | $225 | $181 | $2.4K | $451 | $203 | $1.8K | $1.7K |
| Retained Earnings | -$94.44M | -$81.92M | -$76.35M | -$63.81M | -$32.20M | -$19.43M | -$12.08M | -$5.14M | -$111.1M | -$76.65M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $0 | -$1.2K | -$1.6K |
| **Total Stockholders' Equity** | $5.89M | $1.51M | $5.29M | $10.38M | $38.72M | $22.16M | $10.58M | -$1.27M | -$2.90M | $59.32M |
| Total Equity | $5.89M | $1.51M | $5.29M | $10.38M | $38.72M | $22.16M | $10.58M | -$1.27M | -$2.90M | $59.32M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.17M | $8.29M | $7.82M | $10.71M | $4.81M | $795K | $1.80M | $2.43M |
| **Cash & Short-Term Investments** | $8.17M | $8.29M | $7.82M | $10.71M | $4.81M | $795K | $1.80M | $2.43M |
| Other Current Assets | $209K | $146K | $306K | $275K | $81K | $26K | $62K | $44K |
| **Total Current Assets** | $8.38M | $8.57M | $8.36M | $10.99M | $6.06M | $1.36M | $2.31M | $2.99M |
| Property, Plant & Equipment, Net | $385K | $399K | $36K | $41K | -- | -- | -- | $0 |
| Other Non-Current Assets | $28K | $29K | $30K | $31K | $32K | $33K | $34K | $35K |
| **Total Non-Current Assets** | $413K | $428K | $66K | $72K | $32K | $33K | $34K | $35K |
| **Total Assets** | $8.79M | $9.00M | $8.42M | $11.06M | $6.10M | $1.39M | $2.34M | $3.02M |
| Accounts Payable | $779K | $1.33M | $936K | $941K | $1.10M | $1.48M | $1.47M | $937K |
| Other Current Liabilities | -- | -- | -- | $2.3K | -- | -- | -- | $0 |
| **Total Current Liabilities** | $4.25M | $4.68M | $4.55M | $5.17M | -- | -- | -- | $1.51M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | -- | -- | -- | $0 |
| **Total Liabilities** | $4.25M | $4.68M | $4.55M | $5.17M | $1.85M | $2.22M | $2.28M | $1.51M |
| Common Stock | $238 | $53 | $53 | $53 | $94 | $213 | $208 | $1 |
| Retained Earnings | -$102.0M | -$99.04M | -$96.67M | -$94.44M | -$85.46M | -$84.59M | -$83.63M | -$81.92M |
| **Total Stockholders' Equity** | $4.55M | $4.32M | $3.88M | $5.89M | -$4.25M | -$830K | $62K | $1.51M |
| Total Equity | $4.55M | $4.32M | $3.88M | $5.89M | -$4.25M | -$830K | $62K | $1.51M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$1.67M | -$34.43M | -$39.49M |
| Depreciation & Amortization | $7.2K | $4.4K | $10K | $6.7K | $19K | $18K | $127K | $17K | $325K | $277K |
| Stock-Based Compensation | $219K | $274K | $525K | $797K | $559K | $319K | $752K | $31K | $4.22M | $6.57M |
| Change in Receivables | -- | -- | -- | -- | -- | $0 | $690 | $0 | $1.8K | -$12K |
| Change in Inventory | -- | -- | -- | -- | -- | $0 | $1.2K | $0 | $22K | -$454K |
| Change in Payables | -$1.17M | $334K | -$2.26M | $1.31M | -$311K | -$2.8K | -$519K | -$285K | $819K | $309K |
| **Operating Cash Flow** | -$4.83M | -$4.53M | -$12.85M | -$17.60M | -$10.20M | -$10.31M | -$11.58M | $4.18M | -$27.72M | -$32.05M |
| Capital Expenditure | -$577K | $0 | -- | -- | $0 | -$2.6K | $0 | $0 | -$113K | -$559K |
| **Free Cash Flow** | -$5.40M | -$4.53M | -- | -- | -$10.20M | -$10.31M | -$11.58M | $4.18M | -$27.84M | -$32.61M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -$2.00M | -$32.99M | -$38.68M |
| **Investing Cash Flow** | $765K | $0 | $0 | -$1.50M | $0 | -$2.6K | $5.61M | $0 | $24.49M | -$12.24M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $4.13M | $2.87M | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | $0 | -$615K | -- | -- |
| Dividends Paid | -- | -- | -- | -- | -- | $0 | -$134K | $0 | -- | -- |
| **Financing Cash Flow** | $12.34M | $1.06M | $6.64M | $1.99M | $28.30M | $17.69M | $3.58M | $1.44M | $2.6K | $22K |
| **Net Change in Cash** | $8.28M | -$3.47M | -$6.21M | -$17.11M | $18.10M | $7.38M | -$2.39M | $5.61M | -$3.23M | -$44.27M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.99M | -$2.37M | -$2.22M | -$8.98M | -$873K | -$958K | -$1.71M | -$1.46M |
| Depreciation & Amortization | $25K | $14K | $5.9K | $3.8K | $1.1K | $1.1K | $1.1K | $1.1K |
| Stock-Based Compensation | $253K | $206K | $213K | $140K | $23K | $23K | $34K | $51K |
| Change in Payables | $35K | -$231K | -$4.6K | -$1.19M | -$311K | $83K | $255K | $771K |
| **Operating Cash Flow** | -$2.59M | -$2.65M | -$2.89M | -$1.14M | -$1.65M | -$862K | -$1.18M | -$743K |
| **Financing Cash Flow** | $2.55M | $3.16M | $0 | $6.07M | $5.86M | -$141K | $546K | -$107K |
| **Net Change in Cash** | -$121K | $468K | -$2.89M | $5.90M | $4.01M | -$1.00M | -$636K | -$850K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 77.9% | 60.3% | 34.4% |
| **Operating Margin** | -- | -- | -- | -- | -696.3% | -148.8% | -238.5% | -86.3% | -2724.6% | -3946.5% |
| **Net Profit Margin** | -- | -- | -- | -- | -693.8% | -140.5% | -200.2% | -85.6% | -2701.7% | -3907.6% |
| Return on Equity (ROE) | -212.6% | -368.8% | -237.2% | -304.4% | -33.0% | -33.2% | -65.6% | -- | -- | -66.6% |
| Return on Assets (ROA) | -113.2% | -184.4% | -190.4% | -215.7% | -31.3% | -29.5% | -49.9% | -25.2% | -98.4% | -62.5% |
| Current Ratio | 2.13x | 1.98x | -- | -- | -- | -- | -- | 5.76x | 5.91x | 16.06x |
| Quick Ratio | 2.07x | 1.61x | -- | -- | -- | -- | -- | 5.60x | 5.83x | 15.94x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -64.8% | +51.0% | +77.6% | +53.1% | +26.1% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +98.0% | +120.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -377.2% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -377.2% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -364.3% | -334.4% | -336.1% | -212.6% | -- | -- | -9003.4% | -368.8% |
| Return on Assets (ROA) | -188.4% | -160.5% | -154.7% | -113.2% | -82.1% | -366.4% | -238.1% | -184.4% |
| Current Ratio | 1.97x | 1.83x | 1.84x | 2.13x | -- | -- | -- | 1.98x |
| Quick Ratio | 1.92x | 1.77x | 1.72x | 2.07x | -- | -- | -- | 1.61x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
